Spinal Cord Injury or Dysfunction Quality of Life Rating Scale (SCIDQLRS) (IANR 2022 version)

Ramón-Cueto, 1994, Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants, Exp Neurol, 127, 232, 10.1006/exnr.1994.1099 Ramón-Cueto, 1995, Olfactory bulb ensheathing glia: a unique cell type with axonal growth-promoting properties, Glia, 14, 163, 10.1002/glia.440140302 Ramon-Cueto, 2011, Olfactory ensheathing glia for nervous system repair, Exp Neurol, 229, 1, 10.1016/j.expneurol.2011.03.011 Huang, 2002, Preliminary report on clinical trial of olfactory ensheathing cell transplantation for spinal cord injury (in Chinese), J Navy General Hospital, 15, 18 Huang, 2003, Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury, Chin Med J, 116, 1488 Huang, 2004, Clinical study of olfactory ensheathng cells transplant for chronic spinal cord injury (in Chinese), Chin J Stereotact Funct Neurosurg, 17, 348 Huang, 2006, Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury, Chin J Reparative Reconstr Surg, 20, 434 Huang, 2007, Introduction of spinal cord injury functional rating scale of Xishan Hospital (in Chinese), J Clin Rehabilitative Tissue Eng Res, 30, 5928 2008, Spinal cord injury functional rating scale (in Chinese), Chin J Reparative Reconstr Surg, 22, 1021 Huang, 2012, Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury, Cell Transplant, 21, S23, 10.3727/096368912X633734 Derakhshanrad, 2013, Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study, Cell Transplant, 22, S139, 10.3727/096368913X672109 Rao, 2013, Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury, Cell Transplant, 22, S21, 10.3727/096368913X672127 Liu, 2013, Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells, Cytotherapy, 15, 185, 10.1016/j.jcyt.2012.09.005 Saberi, 2014, Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study, Cell Transplant, 23, S19, 10.3727/096368914X684943 Chen, 2014, A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries, Cell Transplant, 23, S35, 10.3727/096368914X685014 Derakhshanrad, 2018, Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: a double-blind randomized controlled clinical trial, J Neurosurg Spine, 30, 19, 10.3171/2018.6.SPINE18209 Derakhshanrad, 2018, Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial, J Neurosurg Spine, 29, 97, 10.3171/2017.11.SPINE17769 Yang, 2021, Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study, Cytotherapy, 23, 57, 10.1016/j.jcyt.2020.09.012 Karamehmetoğlu, 1997, The functional independence measure in spinal cord injured patients: comparison of questioning with observational rating, Spinal Cord, 35, 22, 10.1038/sj.sc.3100341 Granger, 1993, Performance profiles of the functional independence measure, Am J Phys Med Rehabil, 72, 84, 10.1097/00002060-199304000-00005 Catz, 1997, SCIM—spinal cord independence measure: a new disability scale for patients with spinal cord lesions, Spinal Cord, 35, 850, 10.1038/sj.sc.3100504 Itzkovich, 2002, Rasch analysis of the Catz-Itzkovich spinal cord independence measure, Spinal Cord, 40, 396, 10.1038/sj.sc.3101315 Dittuno, 2001, Walking index for spinal cord injury (WISCI II): scale revision, Spinal Cord, 39, 654, 10.1038/sj.sc.3101223 Scivoletto, 2014, Walking Index for Spinal Cord Injury version II in acute spinal cord injury: reliability and reproducibility, Spinal Cord, 52, 65, 10.1038/sc.2013.127 Marino, 1993, Assessing selfcare status in quadriplegia: comparison of the quadriplegia index of function (QIF) and the functional independence measure (FIM), Paraplegia, 31, 225 Krassioukov, 2012, International standards to document remaining autonomic function after spinal cord injury, J Spinal Cord Med, 35, 201, 10.1179/1079026812Z.00000000053 Round, 2017, An evaluation of the international standards to document remaining autonomic function after spinal cord injury: input from the international community, Spinal Cord, 55, 198, 10.1038/sc.2016.152 Albu, 2015, Deficient conditioned pain modulation after spinal cord injury correlates with clinical spontaneous pain measures, Pain, 156, 260, 10.1097/01.j.pain.0000460306.48701.f9 Smith, 2002, Clinical measurement of muscle tone using a velocity-corrected modified Ashworth scale, Am J Phys Med Rehabil, 81, 202, 10.1097/00002060-200203000-00008